Tirzepatide hydrochloride

Tirzepatide hydrochloride (LY3298176 hydrochloride) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that is being developed for the treatment of type 2 diabetes.
Read more
€0.00 (tax incl.)
Reference:
HY-P1731B
Product Details
HY-P1731B

Data sheet

Size
Multiple sizes
Reactivity
GCGR
Application
Metabolism-sugar/lipid metabolism

Menu

Settings